WT-1 Overexpression in Acute Myeloid Leukemia and Myelodysplastic Syndromes
The Wilms tumor gene was identified as a tumor suppressor gene responsible for a particu-lar type of kidney tumor. Several years ago, it was demonstrated that it is also overexpressed in acute and chronic leukemias. Although the exact role of this gene in the hematopoietic system is still quite completely obscure, it represents a reliable marker for the detection of the presence of leukemic cells. WT1 quantitative assessment may therefore represent a useful tool for the diagnosis and follow up of leukemia patients. In this chapter, we describe the method for the quantification of WT1 transcript by real-time polymerase chain reaction.
- Measurement of Protein Expression of p53, p21WAF1, and Rb in Patients with Surgically Treated Hepatocellular Carcinoma by Using
- Methods for Analyzing Checkpoint Responses in Caenorhabditis elegans
- Isolation of DNA From Tumor Samples
- Other Lymphoid Malignancies: Cytogenetic Techniques
- The EGFR Pathway as an Example for Genotype: Phenotype Correlation in Tumor Genes
- Immunoscope Analysis of T-Lymphocytes Infiltrating Melanocytic Tumors
- Surrogate Markers of Angiogenesis and Metastasis
- Analysis of Targets and Functions Coregulated by MicroRNAs
- RNAi Technology to Block the Expression of Molecules Relevant to Metastasis: The Cell Adhesion Molecule CEACAM1 as an Instructiv
- Tumor-Specific Metastasis to Lung Using Reporter Gene-Tagged Tumor Cells